ACH-000029
/ Ache Lab, Otsuka
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
February 01, 2023
To Assess the Safety, Tolerability and Pharmacokinetics of ACH-000029 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=8 | Terminated | Sponsor: Syneos Health | N=24 ➔ 8 | Recruiting ➔ Terminated; Study was halted since a Significant Safety Issue (SSI) was reported.
Enrollment change • Trial termination
May 24, 2022
To Assess the Safety, Tolerability and Pharmacokinetics of ACH-000029 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=24 | Recruiting | Sponsor: Syneos Health | Not yet recruiting ➔ Recruiting
Enrollment open
May 06, 2022
To Assess the Safety, Tolerability and Pharmacokinetics of ACH-000029 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=24 | Not yet recruiting | Sponsor: Syneos Health
New P1 trial
1 to 3
Of
3
Go to page
1